Skip to main content
Premium Trial:

Request an Annual Quote

Gregory Phelps, Gordon Brunner, John Reed

Premium

Ardais has named Gregory Phelps CEO, the company said Jan. 20.

Phelps, 53, comes to Ardais from Dyax, where he was vice chairman and was responsible for corporate development.

“Greg is well known as an industry leader with strong business management skills, extensive operations experience, knowledge of R&D management, and expertise in the development of new products and new businesses on a global scale,” said Ardais’ Chairman Jeffrey Otten.


Third Wave Technologies has appointed Procter & Gamble veteran Gordon Brunner, 64, to its board of directors, the company announced Jan. 21.

Gordon, whose positions at P&G included senior VP, chief technology officer, head of worldwide research, and a place on the board, said “there is a global need for genetic testing products.”


Genome BioSciences has tapped John Reed to sit on its scientific advisory board, the company said Jan. 21.

Reed, 44, is president of the Burnham Institute and joins Paul Hasty of the University of Texas, San Antonio, who was the first SAB member appointed this year.

Filed under

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.